# Efficacy Study of Iferanserin to Treat Hemorrhoids

> **NCT01483833** · PHASE2 · COMPLETED · sponsor: **Ventrus Biosciences, Inc** · enrollment: 121 (actual)

## Conditions studied

- Hemorrhoids

## Interventions

- **DRUG:** Iferanserin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01483833
- **Lead sponsor:** Ventrus Biosciences, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-09
- **Primary completion:** 2002-08
- **Final completion:** 2002-08
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2013-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01483833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01483833, "Efficacy Study of Iferanserin to Treat Hemorrhoids". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01483833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*